Viridian Therapeutics, Inc.\DE ($VRDN)
Fairmount Funds Management LLC โ Director
Shares
1,176,470
Price
$17.00
Total Value
$19,999,990.00
P&L
+14.1% (+$2,823,528.00)
Nearby Earnings
May 4, 2026
Transaction Details
| Insider | Fairmount Funds Management LLC |
|---|---|
| Title | Director |
| Transaction Date | May 11, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Fairmount Healthcare Fund II L.P. |
| Filing Date | May 13, 2026 |
| Shares Purchased | 1,176,470 |
| Price per Share | $17.00 |
| Total Value | $19,999,990.00 |
| Shares Owned After | 5,090,928 |
| Derivative | No |
| Accession Number | 0001104659-26-060294 |
| Document | View SEC Filing |